MedPath

Adjuvant Therapy for Intrauterine Adhesions Between Two Groups

Not Applicable
Completed
Conditions
Asherman Syndrome
Registration Number
NCT02867202
Lead Sponsor
Wenzhou Medical University
Brief Summary

This study was taken out to compare two mechanical devices (intrauterine balloon and Intrauterine Contraceptive Device Plus Foley Catheter) in the therapy for intrauterine adhesions after hysteroscopic adhesiolysis. Participates were assigned into two groups by randomly.

Detailed Description

Intrauterine balloon and Intrauterine Contraceptive Device Plus Foley Catheter are both effective in the therapy for intrauterine adhesion.

The Intrauterine Contraceptive Device Plus Foley Catheter are usually inserted into the uterine after hysteroscopic adhesiolysis. Foley Catheter is removed after three days while intrauterine device is removed two or three month later.

The heart-shaped intrauterine balloon is designed to fit into the cavity of the uterus, and usually removed on the 7th day after surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
171
Inclusion Criteria
  • Moderate to severe intrauterine adhesion (AFS score ≥5)
  • Agreement to have a second-look hysteroscopy
  • no previous history of hysteroscopic adhesiolysis
Exclusion Criteria
  • Minimal adhesion (AFS score<5)
  • Previous hysteroscopic adhesiolysis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
the AFS Score at Second-look Hysteroscopy2 or 3 months after the surgery

The AFS score is based on the American Fertility Society (AFS) Classification of Intra-uterine adhesions( 1988 version)The total range of AFS score is from 0 to 12, and the higher the score is, the worse the outcome is.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

the 1st Affiliated Hospital of Wenzhou Medical University

🇨🇳

Wenzhou, Zhejiang, China

the 1st Affiliated Hospital of Wenzhou Medical University
🇨🇳Wenzhou, Zhejiang, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.